Pegourie, B., Karlin, L., Benboubker, L., Orsini‐Piocelle, F., Tiab, M., Auger‐Quittet, S., Rodon, P., Royer, B., Leleu, X., Bareau, B., Cliquennois, M., Fuzibet, J., Voog, E., Belhadj‐Merzoug, K., Decaux, O., Rey, P., Slama, B., Leyronnas, C., Zarnitsky, C., Boyle, E., Bosson, J. L., Pernod, G., & , (n.d.). apixaban for the prevention of thromboembolism in immunomodulatory‐treated myeloma patients: Myelaxat, a phase 2 pilot study. American journal of hematology, 94(6), 635–640. http://access.bl.uk/ark:/81055/vdc_100082274167.0x000038